Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 25;30(4):3609-3626.
doi: 10.3390/curroncol30040275.

Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?

Tongyu C Wikramanayake  1 , Nicole I Haberland  1 , Aysun Akhundlu  1 , Andrea Laboy Nieves  1 , Mariya Miteva  1
Affiliations
Review

Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?

Tongyu C Wikramanayake et al. Curr Oncol. .

Abstract

Millions of new cancer patients receive chemotherapy each year. In addition to killing cancer cells, chemotherapy is likely to damage rapidly proliferating healthy cells, including the hair follicle keratinocytes. Chemotherapy causes substantial thinning or loss of hair, termed chemotherapy-induced alopecia (CIA), in approximately 65% of patients. CIA is often ranked as one of the most distressing adverse effects of chemotherapy, but interventional options have been limited. To date, only scalp cooling has been cleared by the US Food and Drug Administration (FDA) to prevent CIA. However, several factors, including the high costs not always covered by insurance, preclude its broader use. Here we review the current options for CIA prevention and treatment and discuss new approaches being tested. CIA interventions include scalp cooling systems (both non-portable and portable) and topical agents to prevent hair loss, versus topical and oral minoxidil, photobiomodulation therapy (PBMT), and platelet-rich plasma (PRP) injections, among others, to stimulate hair regrowth after hair loss. Evidence-based studies are needed to develop and validate methods to prevent hair loss and/or accelerate hair regrowth in cancer patients receiving chemotherapy, which could significantly improve cancer patients' quality of life and may help improve compliance and consequently the outcome of cancer treatment.

Keywords: bimatoprost; minoxidil; photobiomodulation therapy; scalp cooling.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Current approaches to prevent and treat CIA.
See this image and copyright information in PMC

References

    1. World Cancer Research Fund International Worldwide Cancer Data. [(accessed on 14 February 2023)]. Available online: https://www.wcrf.org/cancer-trends/worldwide-cancer-data/
    1. Wilson B.E., Jacob S., Yap M.L., Ferlay J., Bray F., Barton M.B. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: A population-based study. Lancet Oncol. 2019;20:769–780. doi: 10.1016/S1470-2045(19)30163-9. - DOI - PubMed
    1. Amarillo D., de Boni D., Cuello M. Chemotherapy, Alopecia, and Scalp Cooling Systems. Actas Dermosifiliogr. 2022;113:278–283. doi: 10.1016/j.ad.2021.09.003. - DOI - PubMed
    1. Freites-Martinez A., Shapiro J., Goldfarb S., Nangia J., Jimenez J.J., Paus R., Lacouture M.E. Hair disorders in patients with cancer. J. Am. Acad. Dermatol. 2019;80:1179–1196. doi: 10.1016/j.jaad.2018.03.055. - DOI - PMC - PubMed
    1. Miller K.D., Nogueira L., Devasia T., Mariotto A.B., Yabroff K.R., Jemal A., Kramer J., Siegel R.L. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 2022;72:409–436. doi: 10.3322/caac.21731. - DOI - PubMed

Publication types

Substances